Prestige Consumer Healthcare Inc. PBH

$46.19 +1.92% at last close
Market Cap$2.19 billion
P/E Ratio—
Div Yield—
Volume500.4K
52-Week Range $41.77$71.07

Analyst Ratings

Consensus
Hold — 1 Buy · 2 Hold · 0 Sell (3 analysts)
Avg. Price Target
$68.00 (+47.2% upside)

Full PBH forecast & analyst actions →

Key Stats

Today's Range
$45.23 – $46.41
50-Day Range
$41.77 – $53.40
52-Week Range
$41.77 – $71.07
Volume
500K shs
Average Volume
600K shs
Market Cap
$2.19 billion
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
14.85%
Days to Cover
17.88

About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Sector
PHARMACEUTICAL PREPARATIONS
Employees
890
Exchange
XNYS
Listed
2005-02-10

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.